Lazard Asset Management’s Allogene Therapeutics ALLO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-96
| Closed | – | – | 2292 |
|
|
2024
Q4 | $0 | Hold |
96
| – | – | ﹤0.01% | 2263 |
|
|
2024
Q3 | $0 | Sell |
96
-160
| -63% | – | ﹤0.01% | 2251 |
|
|
2024
Q2 | $0 | Sell |
256
-3,605
| -93% | – | ﹤0.01% | 2217 |
|
|
2024
Q1 | $16K | Sell |
3,861
-2,137
| -36% | -$8.86K | ﹤0.01% | 1855 |
|
|
2023
Q4 | $18K | Buy |
5,998
+249
| +4% | +$747 | ﹤0.01% | 2062 |
|
|
2023
Q3 | $17K | Buy |
5,749
+250
| +5% | +$739 | ﹤0.01% | 2113 |
|
|
2023
Q2 | $26K | Buy |
5,499
+1,783
| +48% | +$8.43K | ﹤0.01% | 2047 |
|
|
2023
Q1 | $18K | Buy |
3,716
+806
| +28% | +$3.9K | ﹤0.01% | 2064 |
|
|
2022
Q4 | $17K | Buy |
+2,910
| New | +$17K | ﹤0.01% | 2147 |
|
|
2021
Q3 | – | Sell |
-1,848
| Closed | -$48K | – | 2141 |
|
|
2021
Q2 | $48K | Buy |
+1,848
| New | +$48K | ﹤0.01% | 1610 |
|